Oklahoma OMMA Fires Cannabis Specialist from Advisory Council
The Oklahoma Medical Marijuana Authority removed a cannabis specialist from its advisory council, raising questions about governance and stakeholder representation.
Exterior of historic classic palace with dome and decorative pillars near spacious staircase at dark peaceful night
Specialist Removed from OMMA Advisory Council
OMMA terminated a cannabis specialist from its advisory council on May 31, 2026, without publicly disclosing the grounds for removal. The Oklahoma Medical Marijuana Authority maintains an advisory council under Okla. Stat. tit. 63 § 427.1 et seq., which requires representation from licensed operators, patients, and subject-matter experts.
The specialist's identity hasn't been confirmed in publicly available filings. Neither have the specific grounds for termination. OMMA hasn't issued a formal press release detailing the decision.
Advisory Council Composition Under Oklahoma Law
Oklahoma statute mandates that the OMMA advisory council include stakeholders from across the medical marijuana supply chain, including cultivators, processors, dispensaries, and patients. The council advises the agency on rulemaking, licensing standards, and compliance enforcement.
On a strict reading of Okla. Stat. tit. 63 § 427.8, the advisory council serves in a consultative capacity only. Its recommendations aren't binding. But the council's composition directly influences the agency's regulatory priorities and the scope of stakeholder input on policy development.
- Cultivators and processors
- Dispensary operators
- Medical marijuana patients
- Subject-matter experts (e.g., cannabis specialists, physicians, compliance professionals)
Implications for Stakeholder Representation
The removal of a cannabis specialist reduces the technical expertise available to the advisory council at a time when OMMA is finalizing rules on product testing, THC potency caps, and packaging standards. Oklahoma's medical marijuana market generated over $1.1 billion in sales in 2025, according to OMMA revenue data.
Stakeholder groups have raised concerns that reduced representation from subject-matter experts may tilt policy discussions toward political considerations rather than operational or scientific evidence. No formal complaint has been filed with OMMA or the Oklahoma Legislature as of this report.
Recent OMMA Regulatory Activity
OMMA has initiated several rulemaking proceedings in 2026. These include proposed amendments to testing protocols and pesticide limits. The agency published a notice of proposed rulemaking (NPRM) in April 2026 addressing residual solvent testing for concentrates and edibles.
The advisory council's input on these technical standards is typically solicited during the public comment period, which closes June 15, 2026. The specialist's removal occurs midway through the comment window for the solvent-testing NPRM.
Governance and Appointment Authority
Under Oklahoma law, OMMA's executive director holds appointment and removal authority for advisory council members. The director isn't required to provide cause for removal, though the agency's enabling statute requires the council to maintain "balanced representation" across stakeholder categories.
The current OMMA executive director was appointed in January 2026 following a reorganization of the Oklahoma State Department of Health. The agency hasn't commented on whether the removal was related to policy disagreements, procedural violations, or other administrative factors.
What to Watch
Observers will track whether OMMA appoints a replacement cannabis specialist to the advisory council before the June 15 close of the solvent-testing comment period. The agency's next public meeting is scheduled for June 10, 2026. It may address council composition.
For full background on Oklahoma's medical marijuana regulatory framework, see the CannIntel topic hub on the Oklahoma Medical Marijuana Authority.
Sources
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.
Related from Laws
DEA marijuana rescheduling triggers coverage, compliance shifts
Federal reclassification to Schedule III opens medical access and insurance questions while creating new regulatory pathways.
DEA Cannabis Form Raises Fifth Amendment Self-Incrimination Concerns
Legal experts warn new DEA registration form may compel applicants to disclose federally illegal activity under penalty of perjury.
Cannabis Edibles Plus Alcohol Impair Drivers Beyond Detection Limits
New research shows combined THC and ethanol consumption produces measurable impairment that current roadside tests cannot detect.
More from the newsroom
Alabama Opens First Medical Cannabis Dispensary, Eleven More Licensed
The state's inaugural dispensary began serving patients this week, with nearly a dozen additional locations approved to launch in coming weeks.
Sealed vs Vented Grow Rooms: The Energy Math Nobody Runs
Most growers pick HVAC based on vendor advice, not actual BTU loads. Here's how to calculate whether sealed or vented makes economic sense at your scale.
Federal Medical Marijuana Acceptance Leaves Implementation Unclear
After decades of prohibition, federal agencies now recognize medical cannabis — but no regulatory framework exists to operationalize that shift.